Julia Cheek

She spent more on bloodwork than rent, so she created $49 test kits now sold at CVS.

In 2015, Julia Cheek spent over $2k on lab work just to figure out… a vitamin imbalance.

The experience? Slow. Confusing. Expensive.

So she built the fix herself.

Everlywell started as a simple idea: lab testing should be easy, affordable, and done at home.

No waiting rooms. No surprise bills. No doctor’s note required.

By 2017, Julia landed a Shark Tank deal with Lori Greiner.

Within five years, Everlywell was on the shelves at CVS and Target, and selling millions of at-home tests from food sensitivity to STIs.

But she wasn’t just selling kits, she was rebuilding an entire system.

In 2021, Julia acquired two major companies and formed Everly Health, a diagnostics giant serving over 20 million people a year.

By 2022, her company had raised $170M at a $3.6B valuation.

She’s since been named to Fortune’s 40 Under 40, Forbes’ Women to Watch, and Create & Cultivate’s 100 Women Changing the World.

She also serves on boards for AstraZeneca and Headspace Health.

But Julia’s not just a CEO.

She’s a former corporate strategy exec and Harvard Business School Baker Scholar.

Multi-time World Champion equestrian, a new mom.

And an angel investor in over a dozen early-stage startups... most led by underrepresented founders.